Doxycycline / Molnupiravir / Meloxicam Topical Oral Paste Compounded for Cats

Doxycycline / Molnupiravir / Meloxicam Topical Oral Paste Compounded for Cats

Specialty Veterinary Pharmacy (SVPMEDS) compounds Doxycycline / Molnupiravir / Meloxicam Topical Oral Paste for cats according to patient-specific prescriptions from licensed veterinarians.

This three-ingredient preparation combines doxycycline, molnupiravir, and meloxicam in a chicken-flavored, anhydrous oral paste base. It is formulated for administration within the oral cavity as directed by the prescribing veterinarian.

SVPMEDS offers individualized concentrations based on the veterinarian’s prescription and the pharmacy’s compounding capabilities.

Three-Ingredient Compounded Topical Oral Paste

SVPMEDS prepares this nonsterile compounded formulation using an anhydrous oral paste base for administration within the mouth.

  • Three Active Ingredients: Combines doxycycline, molnupiravir, and meloxicam in one compounded preparation.
  • Topical Oral Paste: Formulated for administration within the oral cavity according to veterinary instructions.
  • Chicken-Flavored: Prepared with vegan chicken flavor.
  • Anhydrous Paste Base: Uses an anhydrous oral paste vehicle.
  • Individualized Concentrations: Compounded according to patient-specific prescription requirements.
  • Pharmacist Consultation: SVPMEDS pharmacists are available to discuss formulation options and prescription requirements with veterinary professionals.

Popularly Prescribed Concentrations

Based on SVPMEDS prescription dispensing history, previously compounded concentrations include:

  • Doxycycline 25 mg/mL / Molnupiravir 85 mg/mL / Meloxicam 0.0625 mg/mL
  • Doxycycline 60 mg/mL / Molnupiravir 204 mg/mL / Meloxicam 0.15 mg/mL

Concentrations are listed in the order doxycycline / molnupiravir / meloxicam. Availability of specific concentrations is subject to pharmacist review and formulation capabilities.

About the Active Ingredients

Doxycycline

Doxycycline is a tetracycline-class antibiotic used in veterinary medicine for certain susceptible bacterial infections. The prescribing veterinarian determines whether antimicrobial therapy is appropriate for an individual patient.

Molnupiravir

Molnupiravir, also known as EIDD-2801, is an antiviral compound that has been investigated in veterinary medicine, including research involving feline viral diseases. Its use requires consideration of the available evidence, potential risks, and patient-specific circumstances.

Meloxicam

Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) with anti-inflammatory and analgesic properties. Its use in cats requires careful veterinary oversight because of important safety considerations, particularly with repeated dosing.

Important: The presence of these three ingredients in a compounded preparation does not establish the clinical effectiveness or safety of their combined use for a particular condition.

Feline Stomatitis and Veterinary Care

Feline chronic gingivostomatitis (FCGS), commonly referred to as feline stomatitis, is a painful inflammatory condition affecting tissues within a cat’s mouth.

Common clinical signs may include:

  • Inflammation of the gums and other oral tissues
  • Oral discomfort or difficulty eating
  • Excessive drooling
  • Changes in grooming behavior
  • Decreased appetite or weight loss
  • Persistent inflammation affecting the oral cavity

Feline stomatitis is a complex condition involving immune-mediated inflammation. Research has identified associations with alterations in the oral microbiome and certain viral infections, including feline calicivirus (FCV).

Veterinary management may involve dental evaluation, treatment of contributing conditions, and individualized medical or surgical interventions.

Veterinarians may request patient-specific compounded medications as part of an individualized care plan. Research into antiviral and combination medication approaches for feline stomatitis is ongoing, and the effectiveness and safety of this specific compounded formulation for the condition have not been established through controlled clinical studies.

Diagnosis, treatment selection, and patient monitoring remain the responsibility of the prescribing veterinarian.

Formulation and Compounding

SVPMEDS prepares Doxycycline / Molnupiravir / Meloxicam Topical Oral Paste using a nonsterile compounding process and an anhydrous oral paste formulation.

The formulation contains:

  • Doxycycline hyclate USP powder
  • Molnupiravir powder
  • Meloxicam
  • Anhydrous oral paste base
  • Anhydrous sweetened formulation vehicle
  • Vegan chicken flavor

SVPMEDS follows established pharmacy procedures for ingredient verification, preparation, labeling, and dispensing. Each prescription is prepared according to the prescribing veterinarian’s instructions and applicable compounding requirements.

Specific concentrations, quantities, and formulation availability are subject to pharmacist review.

Administration and Handling Information

Doxycycline / Molnupiravir / Meloxicam Topical Oral Paste is a compounded preparation formulated for administration within the oral cavity of cats.

The prescribing veterinarian determines the appropriate application method, amount, frequency, and duration of treatment based on the individual patient’s needs.

Because the preparation is administered within the mouth, some medication may be swallowed, and systemic absorption and adverse effects are possible.

Follow the veterinarian’s instructions and the prescription label. Contact the prescribing veterinarian or SVPMEDS pharmacist if clarification is needed regarding administration, storage, or handling.

Important Safety and Handling Precautions

  • Meloxicam: Repeated use of meloxicam in cats has been associated with acute renal failure and death. The veterinarian should assess the patient’s health status, concurrent medications, and monitoring requirements.
  • Molnupiravir: Potential reproductive and genetic toxicity concerns warrant careful handling. Avoid unnecessary exposure to the preparation.
  • Doxycycline: Use only according to veterinary instructions. Report suspected adverse reactions or administration difficulties to the veterinarian.
  • Concurrent Medications: Do not administer additional NSAIDs or corticosteroids unless specifically directed by the prescribing veterinarian.
  • Storage: Follow the storage conditions and beyond-use date printed on the prescription label.
  • Missed Applications: Contact the prescribing veterinarian for instructions rather than administering an additional amount without direction.
  • Monitoring: Follow the veterinarian’s recommendations for monitoring and promptly report suspected adverse reactions.

Handling Warning: Individuals who are pregnant, may become pregnant, or are breastfeeding should consult the dispensing pharmacist and an appropriate healthcare professional regarding handling precautions and potential exposure risks.

Other Molnupiravir Compounded Preparations

SVPMEDS also offers additional compounded molnupiravir dosage forms pursuant to patient-specific veterinary prescriptions.

These preparations differ in their ingredients and dosage forms and should not be substituted for one another without direction from the prescribing veterinarian.

Prescription and Compounding Information

SVPMEDS compounds Doxycycline / Molnupiravir / Meloxicam Topical Oral Paste according to patient-specific prescriptions from licensed veterinarians.

Prescription Required: A valid prescription from a licensed veterinarian is required before this medication can be prepared and dispensed.

Compounded Medication: This combination oral paste is a compounded preparation and is not an FDA-approved animal drug. Compounding and dispensing are subject to applicable federal and state requirements.

Veterinary Oversight: The prescribing veterinarian is responsible for determining whether the combination is appropriate for an individual patient, including the prescribed concentrations, administration instructions, treatment duration, and necessary monitoring.

Frequently Asked Questions

What is Doxycycline / Molnupiravir / Meloxicam Topical Oral Paste?

It is a patient-specific compounded preparation containing doxycycline, molnupiravir, and meloxicam in an anhydrous oral paste base formulated for administration within the mouth.

Is this preparation prescribed for feline stomatitis?

A licensed veterinarian may prescribe this formulation as part of an individualized treatment plan. Feline stomatitis requires comprehensive veterinary evaluation, and the effectiveness and safety of this specific combination for the condition have not been established through controlled clinical studies.

Where should the paste be applied?

The prescribing veterinarian determines the appropriate administration method based on the individual patient’s needs. Follow the prescription label and consult the veterinarian or dispensing pharmacist for clarification.

What concentrations are available?

SVPMEDS has previously compounded doxycycline / molnupiravir / meloxicam topical oral paste in concentrations of 25/85/0.0625 mg/mL and 60/204/0.15 mg/mL, respectively. Contact the pharmacy to confirm current availability.

Is the paste flavored?

The formulation includes vegan chicken flavor. Flavoring does not guarantee acceptance by an individual patient.

Can the medication be swallowed during administration?

Because the preparation is administered within the oral cavity, some medication may be swallowed. Systemic absorption and adverse effects remain possible. Follow the veterinarian’s prescribed administration instructions.

Does this preparation require a prescription?

Yes. A valid patient-specific prescription from a licensed veterinarian is required before SVPMEDS can prepare and dispense this compounded medication.

Is this compounded preparation FDA-approved?

No. Doxycycline / Molnupiravir / Meloxicam Topical Oral Paste is a compounded preparation and is not an FDA-approved animal drug.

Submit a Veterinary Prescription

Veterinarians and existing SVPMEDS customers can access the SVPMEDS Portal to submit patient-specific prescriptions.

For questions about concentrations, formulation availability, or prescription requirements, contact the SVPMEDS pharmacy team.